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Abstract Hypokalaemic periodic paralysis (HypoPP) is an 
autosomal dominant muscle disease which has been linked to 
point mutations in the skeletal muscle L-type calcium channel cq 
subunit (~ls). Here, we have introduced one of the point 
mutations causing HypoPP (R528H) into cDNA of the rabbit 
Cqs. Expression of either the wild-type ~tsor the mutant R528H 
Cqs (~ls-Rszsn) subunits was obtained in mouse Ltk cells using 
a selectable xpression vector. The Cqs-Rs28n subunit led to the 
expression of functional L-type Ca z+ channels. Corresponding 
whole-cell Ba 2+ currents exhibit very slow activation and 
inactivation kinetics, typical for recombinant skeletal Ca 2+ 
channel currents. Voltage-dependent activation and inactivation 
properties were similar for ~ts-and ~IS-RS2Sn, as well as their 
sensitivity to the dihydropyridine agonist Bay K 8644. Differ- 
ences in Cqs-and ~ls-Rs28n-directed channels reside in the Ba 2+ 
current density, which was significantly reduced 3.2 fold in cells 
expressing ~lS-RS2Sn It was concluded that the R528H mutation 
of Cqs results in minor differences in the electrophysiological 
properties but significantly reduces the whole-cell Ca z÷ channel 
current in its amplitude. 
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1. Introduction 
Hypokalaemic periodic paralysis (HypoPP) is a genetic 
muscle disorder of autosomal dominant inheritance character- 
ized by acute attacks of muscle weakness concomitant with a 
decrease in the blood potassium level. Linkage studies have 
shown that the HypoPP gene maps to chromosome lq31 32, 
and colocalizes with the gene encoding the cq subunit 
(CACNL1A3) of the skeletal muscle L-type Ca 2+ channel 
[1]. The L-type Ca 2+ channel in skeletal muscle is located in 
the membrane of transverse tubules and consists of five sub- 
units, cq, c~2/8, [3 and 7. It mediates Ca 2+ entry and acts as a 
voltage sensor for the control of calcium release from the 
sarcoplasmic reticulum [2]. Three point mutations resulting 
in non-conservative changes were found within the coding 
sequence of CACNL1A3 [3,4], establishing it as the HypoPP 
gene. These mutations are responsible for arginine-to-histidine 
(R528H, RI239H) and arginine-to-glycine (R1239G) substitu- 
tions. These mutations occur within the IIS4 and IVS4 regions 
of the DHP receptor eq subunit, that are likely to serve as the 
voltage sensor of this ion-conducting subunit [5]. 
The functional consequences of HypoPP mutations are just 
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being explored and pioneer studies have indicated that myo- 
tubes cultured from HypoPP patients exhibit abnormal Ca 2+ 
channel activity [6,7]. The mutations would result in very dis- 
tinct Ca 2+ channel behaviour: a strong reduction of current 
amplitude with the R1239H mutation [6,7]; and a large hy- 
perpolarizing shift of 40 mV in the voltage-dependent inacti- 
vation with the R528H mutation [7]. These preliminary stu- 
dies suggest a loss of function of HypoPP mutated Ca 2+ 
channels which has now to be probed at the molecular level. 
The functional consequences of HypoPP mutations can be 
studied at the molecular level since the cDNA encoding rabbit 
skeletal muscle •1 subunit (Cqs) has been cloned [8,9] and 
expressed in mammalian cells [10]. Using muscular dysgenesis 
(mdg) myotubes that are specifically defective in the func- 
tional Cqs subunit but express the other subunits, c~2/~5, [~ 
and 7, as well as the cardiac isoform, alc [11], recomplemen- 
tation with recombinant alS restored Ca 2+ channel activity as 
well as excitation-contraction coupling [12]. Using mouse 
Ltk- cells (L cells), a cell line which is devoid of the expres- 
sion of any Ca channel subunit [13], expression experiments 
have revealed that a~s encodes by itself functional Ca 2+ chan- 
nels with typical kinetics properties of skeletal muscle L-type 
Ca 2+ channels [13 16]. 
The purpose of our study was to characterize the channel 
activity of the R528H-mutated cqs subunit. Because this mu- 
tation takes place inside the voltage sensor segment IIS4 (for 
review, see [5]), it was hypothesized that activity of the Cqs 
channel might be altered [3]. To avoid putative regulation by 
auxiliary subunits [10,13], we have expressed the 0~IS_R52S H 
subunit in L cells. Previous functional studies of recombinant 
skeletal muscle L-type Ca 2+ channels in L cells [13,16] were 
performed using a cell line named LCa.11, stably transfected 
with rabbit Cqs [14]. Here we have optimized a transfection/ 
selection procedure, using a selectable xpression vector. We 
present evidence that the R528H mutation results in minor 
changes in the electrophysiological properties of the Cqs sub- 
unit but significantly affects current density. 
2. Materials and methods 
2.1. Molecular biology 
The wild-type rabbit Cqs cDNA subcloned into the pCEP4 expres- 
sion vector containing a selectable marker (Invitrogen) was generously 
provided by Dr. L. Garcia (Paris). Transfection with this construct 
(pCEP4cqs) confers resistance to cells cultivated in the presence of 
hygromycin B [17]. The G1583A mutation in the cq s cDNA, which 
results in R528H substitution i the Cqs protein (als RS2SH), was in- 
troduced using a site-directed mutagenesis procedure (Muta-gene, 
Bio-Rad) using the phosphorylated reverse oligonucleotide 5'- 
CGGATGCAGTGCAACACGG-Y and verified by sequencing (Se- 
quenase, USB). The final construct that contains the mutation was 
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named pCEP40hS_R528H. Plasmid DNA for mammalian transfection 
was purified by adsorption to macroporous silica gel anion exchange 
columns (Qiagen). The expression of either czlS or CqS-R528H mRNA 
in transfected cells was verified using RT-PCR. Total RNA from the 
transfected cells was prepared as described earlier [18]. Reverse tran- 
scription was performed using Superscript II (Gibco), according to the 
manufacturer's instruction. The PCR amplification was performed as 
described earlier [3]. The presence of the G1583A mutation in 
~qS-RS~8H transfected cells was verified by the loss of a Bbvl restriction 
site in the corresponding sequence [3]. 
2.2. Cell culture and transfection 
The Ltk- cells (mouse L cells) were grown in DMEM supplemen- 
ted with 10% fetal calf serum, 1.5 mM glutamine, 0.1 gg/ml strepto- 
mycin and 100 UI/ml penicillin (Eurobio). The day before transfec- 
tion, cells were plated to 40-50% confluency on glass coverslips. The 
transfection was performed using Lipofectamine (Gibco), according to 
the manufacturer's instructions. The day after transfection, culture 
medium was supplemented with 200 gg/ml hygromycin B (Sigma), 
and maintained for up to 5 days in this culture condition, prior to 
electrophysiology. 
2.3. Electrophysiology and data analysis 
Barium (Ba 2+) currents were recorded in the whole cell configura- 
tion as described earlier [16,19]. The bathing solution was (in mM): 
Ba(OH)2 40, glutamate, 40; N-methyl-n-glutamine, 80; HEPES, 10; 
MgCI2, 2; pH adjusted to 7.4 with CH3SOaH. Pipettes were filled 
with (in mM): N-methyl-D-glutamine, 110; EGTA, 15; HEPES, 10; 
MgCI2, 2 pH adjusted to 7.3 with CH3SOaH. Pipettes had resistances 
between 2 and 5 Mf~. Capacitive transients were minimized using the 
analog circuitry of the amplifier (Axopatch 200A, Axon Instruments, 
CA). Ba 2+ currents were recorded at various digitizing rates and fil- 
tered at 500 Hz using a four-pole Bessel filter. Stimulation of cells, 
data acquisition and analysis were performed using the pCLAMP 
package (version 5.5; Axon Instruments) and Excel (version 5; Mi- 
crosoft). Inactivation curves were fitted with the Boltzmann equation 
(I= l - l /[ l+exp((V-Vo.5)lk)]), where V0.5 represents the potential 
for half-inactivation. Activation curves were deduced from the cur- 
rent-voltage relationships according to a modified Boltzmann equa- 
tion (I= g(V-  Vrev)/[1 + exp((V- V0.5) / k)]), where Vos represents the 
potential for half-activation. Values were expressed as mean + S.E.M. 
Statistical comparisons between groups of values were made using 
Student's unpaired t-test, where P < 0.05 was considered significant. 
3. Results and discussion 
To test whether the altered behaviour of L-type skeletal 
muscle Ca 2+ channels in HypoPP myotubes [6,7] was specifi- 
cally related to abnormal  activity of the Cqs subunit, it was 
necessary to study the functional properties of Cqs R52SH re- 
combinant  channels in a suitable expression system. Mouse L 
cells that dit not present any Ca 2+ channel activity (n = 42; see 
Fig. 1A) even in the presence of 1 ~tM Bay K 8644 (n= 15; not 
shown) were chosen. For  the purpose of our study, Cqs and 
O~1s R528H cDNAs  were subcloned in a selectable xpression 
vector (pCEP4) containing the gene encoding hygromycin-B- 
phosphotransferase (see section 2). Fol lowing transfection 
with pCEP4a ls  or pCEP4aas-R52sn, cells surviving in the 
presence of hygromycin B (200 gg/ml) for up to 5 days (less 
than 5%) were studied for their expression of Ca 2+ channels. 
Ba 2+ current recordings clearly indicated that expression of 
O~IS or 0~1S_R528 H leads to functional Ca 2+ channels (Fig. 1B 
and C, respectively). This result rules out the hypothesis that 
HypoPP Ca 2+ channels might be silent. Ba 2+ currents were 
detectable in 100% of the tested cells (n = 58), demonstrat ing 
the reliability of  the transfection/selection procedure. 
Here we show that both Cqs-and Cqs a528H-directed currents 
exhibit very slow activation kinetics (Fig. 1B,C). The time-to- 
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Fig. 1. Ba 2+ currents in mouse L cells expressing Cqs or alS-~2SH. 
Holding potential (HP) was -80  mV. The presented traces were re- 
corded for two depolarizing test pulses ( -20 and +20 mV). (A) No 
inward current was recorded in a non-transfected cell using a 1.5 s 
pulse. The membrane capacitance of this cell was 61 pF. (B) Inward 
Ba 2+ current recorded in a cell transfected with pCEP4cqs, using a 
5 s pulse. The membrane capacitance of this cell was 48 pF. (C) 
Similar to B, for a cell transfected with pCEP4ota s R52SH. The mem- 
brane capacitance of this cell was 79 pF. 
alS_R52SH, respectively. The current voltage (I/V) relationships 
for a ls -and Cqs-R52sH-directed Ba 2+ currents can be superim- 
posed (Fig. 2A). Activation occurred near -10  mV and the 
peak of the I /V  curves was obtained at +20 inV. Inactivation 
kinetics were determined using a 1 min depolarizing pulse, 
which is required to reach complete inactivation (see also 
[13]), both for ~ls-and Cqs_Ft52sH-directed Ba 9+ currents 
(Fig. 2B). Time constants of inactivation were found to be 
similar for als-directed Ba 2+ currents (x = 8.3 + 2.4 s; n = 3) 
and for Cqs Ft52sn-directed Ba 2+ currents (x=9.0+1.2  s; 
n=6)  recorded at +20 inV. Voltage-dependent activation 
and inactivation curves were constructed for ~ls-directed 
Ba 2+ currents (Fig. 2C) and for Cqs RS28H-directed Ba 2+ cur- 
rents (Fig. 2D). The potential for half-activation (V0.5) was 
- -14+3 mV (n=6)  for Cqs, and -9+3 mV (n=5)  for 
aaS-RS2SH. These values were not significantly different when 
compared using Student's unpaired t-test (P > 0.05). Particu- 
lar attention was given to determine steady-state inactivation 
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Fig. 2. Electrophysiological properties of als-and alS-R52su-directed Ba 2" currents. (A) Normalized current-voltage r lationships for 
Ohs(squares, n = 3), and alS-R52SVl (circles, n =4). (B) Superimposition f traces recorded during l min pulses to +20 mV (HP -80 mV) in a 
cell transfected with als (upper trace), and a cell transfected with Cqs ar,2sH (lower trace). (C) Voltage-dependent ac ivation (filled squares) and 
inactivation (open circles) curves for Cqs-directed Ba 2+ currents. (D) Voltage-dependent ac ivation (filled squares) and inactivation curves (open 
circles) for Cqs-a52sH-directed Ba 2+ currents. (E) I/V curve for control (filled squares) and Bay K 8644-stimulated (open squares) currents in a 
cell transfected with aas. (F) I/V curve for control (filled squares) and Bay K 8644-stimulated (open squares) currents in a cell transfected 
(~lS-R528H. 
properties precisely. The prepulse duration was 90 s, and the 
cells were stimulated every 4 rain to allow total recovery of the 
maximum of current amplitude between two episodes. Indeed, 
the potential values for half-inactivation were similar ( -46  + 3 
mV, n=7 and -45+4 mV, n=9;  for Cqs and Cqs R52SH, re- 
spectively). Both for aas-and CqS-Ra2sH-directed Ba 2+ currents 
were sensitive to a dihydropyridine agonist, Bay K 8644 (Fig. 
2E,F), and a dihydropyridine antagonist, PN 200-110 (not 
shown). Following Bay K 8644 application (1 p.M), the cur- 
rents were enhanced 6-7 fold in average for Cqs (n = 6) and for 
121S-R528H (n = 5). A leftward shift of the I /V  curve (10 mV) 
was observed following Bay K 8644 application, as previously 
described [13]. Altogether, our data indicate that Cqs-and 
~as-a52sH-directed Ba 2+ currents are similar in their electro- 
physiological parameters. 
The most striking effect related to the expression of recom- 
binant ~lS-R528H channels was observed on current density 
(Fig. 3). To analyze this parameter more precisely, the trans- 
fection procedure was carefully controlled and the current 
recordings were performed using a double blind strategy. 
The Ba 2+ current density was 3.2 fold lower in L cells trans- 
fected wit ~lS-R~2Sla (0.24 + 0.06 pA/pF, n-- 15), compared to 
the cells transfected with wild-type alS (0.78+0.26 pA/pF, 
n = 14). This result, obtained from 3 independent experiments, 
is illustrated in figure 3. 
Thus, an important finding of our study is that the point 
mutation R528H significantly reduces the Ba 2+ current den- 
sity in L cells. Under our experimental conditions, we can 
postulate that the amplitude of Ba 2+ currents is a good index 
of the cq-directed Ca 2+ channel function. The decreased ac- 
tivity of alS-R52su channels can be due to either abnormal 
electrophysiological properties or to alterations at the protein 
level, such as maturation or traffic. To date, three point muta- 
tions (R528H, R1239H and R1239G) of Cqs, linked to the 
HypoPP disease, have been described [3,4]. The relationship 
between various genotypes (R528H and R1239H) and specific 
phenotypes i not immediately obvious, since no clinical signs 
preferentially associated with either mutation has been found 
[20]. In human myotubes, several types of Ca 2+ channels co- 
exist [21], which makes their electrophysiological dissection 
difficult. Nevertheless, recent studies by Lehmann-Horn and 
co-workers [6,7] have described a strong reduction in the am- 
plitude of the slow L-type Ca 2+ current in cultured myotubes 
from patients with the R1239H mutation. Unexpectedly, no 
such reduction in current amplitude was observed in myo- 
tubes from a patient with the R528H mutation [7]. Because 
HypoPP myotubes also express the wild type isoform, Cqs, as 
well as the auxiliary subunits, (zJg, [3 and 7, it is possible that 
some compensatory mechanisms mask the mere biophysical 
consequence of the HypoPP point mutation identified in our 
study. 
The decrease in Ba 2+ current density with (~1S-It528H is un- 
likely to be caused by a change in the macroscopic electro- 
physiological properties of als a52su-directed channels, since 
we did not observe any significant differences in the Ba 2+ 
current parameters, such as kinetics, voltage-dependent ac i- 
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Fig. 3. Histograms representing averaged current density in cells 
transfected with cq s (left) and cells transfected with CqS-RS2SH 
(right). The difference was found significantly different (P<0.05) 
using unpaired Student's t-test (asterisk). 
vation and inactivation, when compared to ~ts-directed chan- 
nels. Moreover, our data regarding wild-type ~lS recombinant 
channels clearly match with previous studies performed in L 
cells, and refering to the LCa. l l  cell line [13 16,19]. Surpris- 
ingly, Sipos et al. [7] reported that R528H mutation, but not 
R1239H, resulted in a profound change in the voltage-depend- 
ence of inactivation, since the potential for half-inactivation 
was shifted by 40 mV towards negative potentials. This latter 
result, was obtained in cultured myotubes of only one patient 
and should be substantiated. Replacement of arginine, a posi- 
tively charged residue, into histidine corresponds to a neutra- 
lizing mutation. Comparatively, a similar mutation (R1448H) 
occurs in the IVS4 segment of the a subunit of Na + channels 
(hSkM1) of patients with paramyotonia congenita nd is re- 
sponsible for only a slight hyperpolarizing shift in steady-state 
inactivation: less than 5 mV [22]. This behaviour was ob- 
served with recombinant Na + channels when the R1448H 
mutation was introduced either into the rat or the human 
SkM1 sequences [22]. Whether the R528H mutation is directly 
responsible for a large hyperpolarizing shift (40 mV) in the 
steady-state inactivation should have been observed in our 
experiments. Another possibility is that auxiliary subunits, 
which are missing in Ltk-  cells, may exert a distinct modula- 
tory role on Cqs-and (Xls_a52sH-directed Ba 2+ currents. It is 
unlikely that the discrepancies between our study and Sipos 
et al. [7] are related to the use of alS eDNA from rabbit in our 
experiments. Indeed, the full length eDNA encoding for the 
human Cqs has recently been cloned [23] and shows 92% of 
homology with its rabbit counterpart [8,9]. Within the IIS4 
segment, the homology reaches 95% and only a conservative 
amino-acid substitution can be found. Therefore, from the 
model of the R1448H mutation of the Na + channel described 
above, it is tempting to speculate that the R528H mutation is 
equivalent in terms of function when introduced within the 
rabbit Sis sequence. 
The preliminary electrophysiological studies of the HypoPP 
mutations have suggested a loss of function as the major 
alteration of the mutated Ca 2+ channels (for a recent review, 
see [24,25]). Our study indicates that this phenomenon relies 
directly to a reduced Ca 2+ channel activity of (~1S-R52SH, in- 
dependently of a substantial change in electrophysiological 
parameters. How a decrease in Ca 2+ current amplitude might 
interfere with proper excitation-contraction coupling is still 
unclear. Moreover, the origin of muscle paralysis and decrease 
in blood potassium [26] remains unexplained. Consequently, 
further studies of the mutated CqS-Rs2sH protein should also 
probe additional parameters, uch as subunit interaction, pro- 
tein quantitation or cellular localization, that would provide a 
better understanding of the HypoPP Ca 2+ channel defect. 
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